Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/fa26c959-2087-470a-96c3-db662b81c34d/
CORT
Corcept Therapeutics IncorporatedSnapshot 2026-07-19 · 0.6w · Fresh
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
0.0%ile
P/E
202.9×
P/S
12.6×
P/B
15.2×
E/P
0.0013
FCF Yield
0.013
EBITDA/EV
0.001
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
100.00000000
/100 — 1=cheapest
VC2 (Trending Value)
100.00000000
/100
VC3 (Buyback)
100.00000000
/100
P/E of 202.9x is premium-priced — the market is paying up for expected growth. VC2 score of 100.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
70.0%ile
ROE
0.075
ROA
0.059
Net Margin
0.062
Op Margin
0.016
GPA
0.927
D/E
0.28
Current
2.86
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.122
Earn Growth
-0.640
Stability
1.040
lower=better
Accruals
-0.089
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.28.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
70.0%ile
6M Return
160.6%
12M Return
27.7%
12-1 Mom
12.8%
Risk-Adj
0.16
Vol 252d
77.8%
Vol 60d
189.0%
↑ Expanding
Max DD 12M
-63.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (189%) is expanding vs long-term (78%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.19
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
0.4%
Sector Quality %ile
79.6%
P/E z-score
3.20
P/B z-score
0.42
Sector Avg OS
64.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (70th) and momentum (70th) but expensive (0th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (70th) but expensive (0th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (189%) significantly exceeds 252-day (78%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
7.4% avg (7 factors)
Quality
B
61.2% avg (8 factors)
Momentum
B
60.9% avg (4 factors)
Risk
F
0.0% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.190 | —7 | — | |
| Value %ile | 0.000 | —7 | — | |
| Quality %ile | 0.700 | —1 | — | |
| Momentum %ile | 0.700 | —2 | — | |
| F-Score | 5.000 | —0 | — | |
| Confidence | 0.940 | —7 | — | |
| Volatility | 0.778 | —7 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
202.86
Earnings Yield (E/P)
0.0013
Price / Sales
12.63
Price / Book
15.23
Price / Cash Flow
80.91
FCF Yield
1.3%
EBITDA / EV
0.1%
Sales Yield (1/P·S)
0.0800
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
7.5%
Return on Assets
5.9%
Net Margin
6.2%
Operating Margin
1.6%
Gross Profit / Assets
Novy-Marx GPA
92.7%
Debt / Equity
0.28
Current Ratio
2.86
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.089
MomentumPrice trend strength over different horizons
6M Return
160.6%
12M Return
27.7%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
12.8%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.16
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
-64.0%
Earnings Stability (CV)
Lower = more stable
1.040
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
100
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
100
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
100
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity